Inozyme Pharma, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2019 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Inozyme Pharma, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2019 to Q2 2024.
- Inozyme Pharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $2.16M, a 34.8% increase year-over-year.
- Inozyme Pharma, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $7.16M, a 4.01% decline year-over-year.
- Inozyme Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7M, a 9.09% decline from 2022.
- Inozyme Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.7M, a 6.94% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)